Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
30.81 BRL | +3.98% | -3.05% | +37.52% |
Apr. 17 | Embraer's Eve says it signed letter of intention with AirX to sell up to 50 eVTOL | RE |
Apr. 09 | Boeing deliveries drop by half in March due to increased quality checks | RE |
Sales 2024 * | 6.28B 32.89B | Sales 2025 * | 7.13B 37.33B | Capitalization | 4.45B 23.27B |
---|---|---|---|---|---|
Net income 2024 * | 219M 1.15B | Net income 2025 * | 328M 1.72B | EV / Sales 2024 * | 0.83 x |
Net Debt 2024 * | 749M 3.92B | Net Debt 2025 * | 563M 2.95B | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
18.3
x | P/E ratio 2025 * |
12.3
x | Employees | 19,179 |
Yield 2024 * |
-
| Yield 2025 * |
3.03% | Free-Float | 93.79% |
Latest transcript on EMBRAER S.A.
1 day | +7.26% | ||
1 week | +0.06% | ||
Current month | -4.59% | ||
1 month | +0.67% | ||
3 months | +48.99% | ||
6 months | +78.24% | ||
Current year | +41.94% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 19-04-30 | |
Antonio Garcia
DFI | Director of Finance/CFO | 58 | 19-12-31 |
Chief Operating Officer | - | 20-07-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Raul Calfat
BRD | Director/Board Member | 71 | 16-12-31 |
Dan Ioschpe
BRD | Director/Board Member | 58 | 20-04-30 |
Chairman | 78 | 10-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 15 M€ | -6.67% | ||
0.04% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 30.81 | +3.98% | 5 194 900 |
24-04-18 | 31.83 | -0.34% | 5,350,700 |
24-04-17 | 31.94 | +0.57% | 4,530,300 |
24-04-16 | 31.76 | +1.08% | 7,477,600 |
24-04-15 | 31.42 | -1.07% | 10,347,500 |
Delayed Quote Sao Paulo, April 19, 2024 at 10:56 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.94% | 4.45B | |
+14.42% | 135B | |
+1.82% | 110B | |
+15.97% | 17.81B | |
+14.17% | 17.31B | |
+6.31% | 4.14B | |
-30.30% | 3.21B | |
-3.28% | 3.22B | |
-27.60% | 1.42B | |
+8.42% | 1.16B |
- Stock Market
- Equities
- EMBR3 Stock